We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Corcept Therapeutics and Xceleron Sign Agreement for Microdosing Study Using Accelerator Mass Spectrometry

News   Jul 26, 2007

 
Corcept Therapeutics and Xceleron Sign Agreement for Microdosing Study Using Accelerator Mass Spectrometry
 
 
Advertisement
 

RELATED ARTICLES

X-rays Give a Window Into Synthetic Fuel Production Under Industrial Conditions

News

Using X-rays from a synchrotron particle accelerator, scientists have now been able to observe for the first time a catalyst during the Fischer-Tropsch reaction that facilitates the production of synthetic fuels under industrial conditions.

READ MORE

Milk Lipids Have Co-evolved With Mammal Species' Needs

News

The findings of a new study indicate a co-evolution of milk lipid composition and the specific needs of the developing organism.

READ MORE

Oat and Rye Bran Boost Gut Microbiome and Benefit Health

News

Consumption of dietary fiber from oat and rye brans supported the growth of beneficial gut microbiota, which in turn benefited cholesterol levels, weight gain, liver inflammation and gut health.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE